Lifeward (NASDAQ: LFWD) grants CFO options on 39,934 shares

Rhea-AI Filing Summary

Lifeward Ltd. reported that Chief Financial Officer Adar Almog received a grant of stock options on 39,934 ordinary shares of the company. The options have an exercise price of $6.53 per share and expire on March 25, 2036.

The grant vests over four years, with 25% of the underlying shares vesting on March 25, 2027, and the remaining shares vesting in equal monthly installments over the following 36 months, contingent on continued service. Following this grant, Almog holds options to acquire 39,934 shares, reflecting routine, compensation-related equity rather than an open-market share purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Adar Almog

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Grant/Award	Option (Right to Buy)	39,934	$0.00	--

Holdings After Transaction: Option (Right to Buy) — 39,934 shares (Direct)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Adar Almog

(Last) (First) (Middle)

C/O LIFEWARD LTD.

2 CABOT RD

(Street)

HUDSON MASSACHUSETTS 01749

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Lifeward Ltd. [ LFWD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option (Right to Buy)	$6.53	03/25/2026		A		39,934		(1)	03/25/2036	Ordinary Shares, no par value per share	39,934	$0	39,934	D

Explanation of Responses:

1. The shares underlying the option shall become vested and exercisable over four (4) years with 25% of the shares vesting on March 25, 2027, with the remainder vesting in equal monthly installments for the following thirty-six (36) months, provided the reporting person's continued service with the Company on each applicable vesting date, subject to acceleration as provided in the applicable plan and non-qualified stock option grant. .

	/s/ Almog Adar	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Lifeward (LFWD) disclose in the latest Form 4 for Adar Almog?

Lifeward reported a compensation-related stock option grant to CFO Adar Almog. He received options over 39,934 ordinary shares at a $6.53 exercise price, vesting over four years and expiring in 2036, reflecting standard executive equity incentives rather than an open-market trade.

How many Lifeward (LFWD) shares are covered by the CFO’s new option grant?

The grant covers options over 39,934 ordinary shares of Lifeward. These options give CFO Adar Almog the right to buy that number of shares at $6.53 per share once vested, subject to the four-year vesting schedule and continued service conditions described in the grant.

What are the exercise price and expiration date of the LFWD options granted to the CFO?

The options granted to CFO Adar Almog have an exercise price of $6.53 per share and expire on March 25, 2036. He can exercise them only as they vest over time, assuming he continues his service with Lifeward through each vesting date.

How do the vesting terms work for the Lifeward (LFWD) CFO’s option grant?

The options vest over four years. Twenty-five percent of the shares vest on March 25, 2027, and the remaining 75% vest in equal monthly installments over the following 36 months, conditioned on Almog’s continued service, with potential acceleration under the applicable plan and grant terms.

Does this Lifeward (LFWD) Form 4 show the CFO buying shares on the open market?

No, the Form 4 reports a stock option grant, not an open-market share purchase. CFO Adar Almog received options as compensation, giving him the right to buy 39,934 shares at $6.53 if he chooses to exercise them after they vest over time.

What is the CFO’s position in LFWD options after this reported transaction?

After this transaction, CFO Adar Almog holds options to acquire 39,934 Lifeward ordinary shares. This entire amount comes from the newly granted award, reflecting his current option position as shown in the filing, subject to vesting and future exercise decisions.